VY-3-135

CAS No. 1824637-41-3

VY-3-135( —— )

Catalog No. M28868 CAS No. 1824637-41-3

VY-3-135 is a metastasis inhibitor and an acetyl- CoA synthetase 2 (ACSS2) modulator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 177 Get Quote
10MG 295 Get Quote
25MG 502 Get Quote
50MG 709 Get Quote
100MG 1008 Get Quote
500MG 2007 Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    VY-3-135
  • Note
    Research use only, not for human use.
  • Brief Description
    VY-3-135 is a metastasis inhibitor and an acetyl- CoA synthetase 2 (ACSS2) modulator.
  • Description
    VY-3-135 is a metastasis inhibitor and an acetyl- CoA synthetase 2 (ACSS2) modulator.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    Fatty Acid Synthase
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1824637-41-3
  • Formula Weight
    429.51
  • Molecular Formula
    C26H27N3O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 50 mg/mL (116.41 mM)
  • SMILES
    CCn1c(cc(cc2)C(NC[C@@H](C)O)=O)c2nc1C(c1ccccc1)(c1ccccc1)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Hussein H, Abu-Zeid K M. 2-hydrazinopyrimidines as precursors for azolopyri-midìnes and pyrimidotriazines expected antimicrobial activity[J]. Egyptian Journal of Chemistry, 2007, 50(6):725-737.
molnova catalog
related products
  • L(-)-Carnitine

    L-carnitine is constituent of striated muscle and liver. It is used therapeutically to stimulate gastric and pancreatic secretions and in the treatment of hyperlipoproteinemias.

  • Orlistat

    Orlistat is a drug designed to treat obesity. Its primary function is preventing the absorption of fats from the human diet, thereby reducing caloric intake.

  • trans-C75

    trans-C75 is an enantiomer of C75. C75 is an inhibitor of fatty-acid synthase (FASN).